| 000 | 00993 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250514022553.0 | ||
| 264 | 0 | _c20020423 | |
| 008 | 200204s 0 0 eng d | ||
| 022 | _a0163-4356 | ||
| 024 | 7 |
_a10.1097/00007691-200202000-00015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBialer, Meir | |
| 245 | 0 | 0 |
_aNew antiepileptic drugs currently in clinical trials: is there a strategy in their development? _h[electronic resource] |
| 260 |
_bTherapeutic drug monitoring _cFeb 2002 |
||
| 300 |
_a85-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnticonvulsants _xpharmacokinetics |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aEpilepsy _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aValproic Acid _xanalogs & derivatives |
| 773 | 0 |
_tTherapeutic drug monitoring _gvol. 24 _gno. 1 _gp. 85-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00007691-200202000-00015 _zAvailable from publisher's website |
| 999 |
_c11716451 _d11716451 |
||